Global Nanopore Sequencing Market, By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), By Type of Nanopore (Solid State, Biological, Hybrid), By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research), By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes), By Region, Competition Forecast & Opportunities, 2026
Global nanopore sequencing market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% during the forecast period. This growth can be attributed to the growing demand for long read sequencing technologies for DNA and RNA sequencing worldwide. Additionally, benefits such as affordability, high accuracy, simultaneous detection of sequences and base modifications, among others associated with nanopore sequencing technology are further expected to fuel the market growth through 2026. Nanopore sequencing provides targeted sequencing with focus on specific genes thereby providing relevant data, optimizing costs and providing path for simplified data analysis. This in turn is expected to support the market growth over the next few years. Besides, the biggest advantage of directly sequencing RNA molecules using the nanopore sequencing is expected to foster the market growth. In traditional RNA sequencing technologies RNA is first converted to cDNA using amplification or reverse transcription which at time introduces bias in the sequencing. However, with nanopore sequencing direct RNA sequencing can be done and it delivers unbiased, full length and highly specific RNA sequences. All these factors are expected to contribute to the market growth in the next five years.
The global nanopore sequencing market is segmented by product, nucleotide sequenced, type, type of nanopore, application, end user, competitional landscape, and regional distribution. Based on product, the market can be split into consumables and instruments. The consumables segment dominated the market in 2020 with a share of around 53.86%. This can be attributed to surge in use of consumables in wide array of procedures such as DNA sequencing and RNA sequencing. In addition, increase in usage of consumables in formerly unmapped applications such as sequencing of novel viruses is expected to help the segment gain significant share during the forecast period.
Major players operating in the global nanopore sequencing market include Oxford Nanopore Technologies Ltd, Illumnia, Inc., F Hoffmann-La Roche AG, 10X Genomics, Inc., Agilent Technologies Inc., NabSys, Inc., Sequenom, Inc., Quantapore, Inc, INanoBio Inc, Thermo Fischer Scientific, Inc., Cyclomics BV, CD Genomics, Electronic Biosciences, Inc., Easi-Genomics, among others. The players operating in the market are following strategies such as mergers & acquisitions, new product/technology development and launches in order to stay competitive in the market and having an edge over the competitors. For instance, in the nanopore sequencing market its Oxford Nanopore Technologies Ltd. which is the pioneer of the technology and dominates the overall nanopore sequencing market. The company is expanding worldwide, opening subsidiaries, launching new products & instruments and investing in development of nanopore sequencing. For instance, in July 2019, Oxford Nanopore Technologies introduced GridION Mk1, a device which can be used to perform PCR-free analysis of cancer-related genes. Additionally, researchers at Fuyang City (China) were the first to sequence COVID-19 samples using Oxford Nanopore Technologies (UK) MinION Mk1C. The team is part of a growing network of public health and CDC labs in China that are deploying Nanopore products for rapid epidemiological surveillance. In February 2019, Nanopore deployed 200 MinIONs to China, and many of these are now in use for viral and bacterial sequencing surveillance programs.
Years considered for this report:
TechSci Research calculated the market size of global nanopore sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, global nanopore sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in global nanopore sequencing market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
The global nanopore sequencing market is segmented by product, nucleotide sequenced, type, type of nanopore, application, end user, competitional landscape, and regional distribution. Based on product, the market can be split into consumables and instruments. The consumables segment dominated the market in 2020 with a share of around 53.86%. This can be attributed to surge in use of consumables in wide array of procedures such as DNA sequencing and RNA sequencing. In addition, increase in usage of consumables in formerly unmapped applications such as sequencing of novel viruses is expected to help the segment gain significant share during the forecast period.
Major players operating in the global nanopore sequencing market include Oxford Nanopore Technologies Ltd, Illumnia, Inc., F Hoffmann-La Roche AG, 10X Genomics, Inc., Agilent Technologies Inc., NabSys, Inc., Sequenom, Inc., Quantapore, Inc, INanoBio Inc, Thermo Fischer Scientific, Inc., Cyclomics BV, CD Genomics, Electronic Biosciences, Inc., Easi-Genomics, among others. The players operating in the market are following strategies such as mergers & acquisitions, new product/technology development and launches in order to stay competitive in the market and having an edge over the competitors. For instance, in the nanopore sequencing market its Oxford Nanopore Technologies Ltd. which is the pioneer of the technology and dominates the overall nanopore sequencing market. The company is expanding worldwide, opening subsidiaries, launching new products & instruments and investing in development of nanopore sequencing. For instance, in July 2019, Oxford Nanopore Technologies introduced GridION Mk1, a device which can be used to perform PCR-free analysis of cancer-related genes. Additionally, researchers at Fuyang City (China) were the first to sequence COVID-19 samples using Oxford Nanopore Technologies (UK) MinION Mk1C. The team is part of a growing network of public health and CDC labs in China that are deploying Nanopore products for rapid epidemiological surveillance. In February 2019, Nanopore deployed 200 MinIONs to China, and many of these are now in use for viral and bacterial sequencing surveillance programs.
Years considered for this report:
- Historical Years: 2016 – 2019
- Base Year: 2020
- Estimated Year: 2021
- Forecast Period: 2022 – 2026
- To analyze the historical growth in the market size of global nanopore sequencing market from 2016 to 2020.
- To estimate and forecast the market size of global nanopore sequencing market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global nanopore sequencing market based on product, nucleotide sequenced, type, type of nanopore, application, end user, region and company.
- To identify dominant region or segment in the global nanopore sequencing market.
- To identify drivers and challenges for global nanopore sequencing market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nanopore sequencing market.
- To identify and analyze the profile of leading players operating in global nanopore sequencing market.
- To identify key sustainable strategies adopted by market players in global nanopore sequencing market.
TechSci Research calculated the market size of global nanopore sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Sequencing Service Providers
- Academic & Research Institutes, Biotechnology Companies and other stakeholders
- Manufacturers, distributors and suppliers of instruments, consumables and other stakeholders
- Organizations, forums, and alliances related to nanopore sequencing
- Market research and consulting firms
Report Scope:
In this report, global nanopore sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Nanopore Sequencing Market, By Product:
- Consumables
- Instruments
- Global Nanopore Sequencing Market, By Nucleotide Sequenced:
- DNA
- RNA
- Global Nanopore Sequencing Market, By Type:
- Direct Current Sequencing
- Synthetic DNA and Horizontal Tunnelling Current Sequencing
- Optical Reading Techniques Sequencing
- Exonuclease Sequencing
- Global Nanopore Sequencing Market, By Type of Nanopore:
- Solid State
- Biological
- Hybrid
- Global Nanopore Sequencing Market, By Application:
- Human Genomics
- Clinical Research
- Plant Research
- Microbiology
- Animal Research
- Global Nanopore Sequencing Market, By End User:
- Biotechnology Companies
- Clinical Laboratories
- Academic & Research Institutes
- Global Nanopore Sequencing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Russia
- Turkey
- Spain
- Asia-Pacific
- China
- Japan
- India
- Singapore
- Taiwan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Company Profiles: Detailed analysis of the major companies present in global nanopore sequencing market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL NANOPORE SEQUENCING MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Product/Service Awareness
5.2. Brand Awareness
5.3. Factors affecting the choice of Nanopore
5.4. Commonly Used Nanopore Sequencing Methods
5.5. Factors Leading to adoption of Nanopore Sequencing
6. GLOBAL NANOPORE SEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables v/s Instruments)
6.2.2. By Nucleotide Sequenced (DNA v/s RNA)
6.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)
6.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)
6.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)
6.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)
6.2.7. By Region
6.2.8. By Company (2020)
6.3. Product Market Map
7. NORTH AMERICA NANOPORE SEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Nucleotide Sequenced
7.2.3. By Type
7.2.4. By Type of Nanopore
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanopore Sequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Nucleotide Sequenced
7.3.1.2.3. By Type
7.3.1.2.4. By Type of Nanopore
7.3.1.2.5. By Application
7.3.1.2.6. By End User
7.3.2. Canada Nanopore Sequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Nucleotide Sequenced
7.3.2.2.3. By Type
7.3.2.2.4. By Type of Nanopore
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Mexico Nanopore Sequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Nucleotide Sequenced
7.3.3.2.3. By Type
7.3.3.2.4. By Type of Nanopore
7.3.3.2.5. By Application
7.3.3.2.6. By End User
8. EUROPE NANOPORE SEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Nucleotide Sequenced
8.2.3. By Type
8.2.4. By Type of Nanopore
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. United Kingdom Nanopore Sequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Nucleotide Sequenced
8.3.1.2.3. By Type
8.3.1.2.4. By Type of Nanopore
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8.3.2. Germany Nanopore Sequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Nucleotide Sequenced
8.3.2.2.3. By Type
8.3.2.2.4. By Type of Nanopore
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. France Nanopore Sequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Nucleotide Sequenced
8.3.3.2.3. By Type
8.3.3.2.4. By Type of Nanopore
8.3.3.2.5. By Application
8.3.3.2.6. By End User
8.3.4. Russia Nanopore Sequencing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Nucleotide Sequenced
8.3.4.2.3. By Type
8.3.4.2.4. By Type of Nanopore
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Turkey Nanopore Sequencing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Nucleotide Sequenced
8.3.5.2.3. By Type
8.3.5.2.4. By Type of Nanopore
8.3.5.2.5. By Application
8.3.5.2.6. By End User
8.3.6. Spain Nanopore Sequencing Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Product
8.3.6.2.2. By Nucleotide Sequenced
8.3.6.2.3. By Type
8.3.6.2.4. By Type of Nanopore
8.3.6.2.5. By Application
8.3.6.2.6. By End User
9. ASIA-PACIFIC NANOPORE SEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Nucleotide Sequenced
9.2.3. By Type
9.2.4. By Type of Nanopore
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Nanopore Sequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Nucleotide Sequenced
9.3.1.2.3. By Type
9.3.1.2.4. By Type of Nanopore
9.3.1.2.5. By Application
9.3.1.2.6. By End User
9.3.2. Japan Nanopore Sequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Nucleotide Sequenced
9.3.2.2.3. By Type
9.3.2.2.4. By Type of Nanopore
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. India Nanopore Sequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Nucleotide Sequenced
9.3.3.2.3. By Type
9.3.3.2.4. By Type of Nanopore
9.3.3.2.5. By Application
9.3.3.2.6. By End User
9.3.4. Singapore Nanopore Sequencing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Nucleotide Sequenced
9.3.4.2.3. By Type
9.3.4.2.4. By Type of Nanopore
9.3.4.2.5. By Application
9.3.4.2.6. By End User
9.3.5. Taiwan Nanopore Sequencing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Nucleotide Sequenced
9.3.5.2.3. By Type
9.3.5.2.4. By Type of Nanopore
9.3.5.2.5. By Application
9.3.5.2.6. By End User
9.3.6. Australia Nanopore Sequencing Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Product
9.3.6.2.2. By Nucleotide Sequenced
9.3.6.2.3. By Type
9.3.6.2.4. By Type of Nanopore
9.3.6.2.5. By Application
9.3.6.2.6. By End User
9.3.7. South Korea Nanopore Sequencing Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Product
9.3.7.2.2. By Nucleotide Sequenced
9.3.7.2.3. By Type
9.3.7.2.4. By Type of Nanopore
9.3.7.2.5. By Application
9.3.7.2.6. By End User
10. SOUTH AMERICA NANOPORE SEQUENCING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Nucleotide Sequenced
10.2.3. By Type
10.2.4. By Type of Nanopore
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanopore Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Nucleotide Sequenced
10.3.1.2.3. By Type
10.3.1.2.4. By Type of Nanopore
10.3.1.2.5. By Application
10.3.1.2.6. By End User
10.3.2. Argentina Nanopore Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Nucleotide Sequenced
10.3.2.2.3. By Type
10.3.2.2.4. By Type of Nanopore
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Nanopore Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Nucleotide Sequenced
10.3.3.2.3. By Type
10.3.3.2.4. By Type of Nanopore
10.3.3.2.5. By Application
10.3.3.2.6. By End User
11. MIDDLE EAST AND AFRICA NANOPORE SEQUENCING MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Nucleotide Sequenced
11.2.3. By Type
11.2.4. By Type of Nanopore
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Nanopore Sequencing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Nucleotide Sequenced
11.3.1.2.3. By Type
11.3.1.2.4. By Type of Nanopore
11.3.1.2.5. By Application
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Nanopore Sequencing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Nucleotide Sequenced
11.3.2.2.3. By Type
11.3.2.2.4. By Type of Nanopore
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. Israel Nanopore Sequencing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Nucleotide Sequenced
11.3.3.2.3. By Type
11.3.3.2.4. By Type of Nanopore
11.3.3.2.5. By Application
11.3.3.2.6. By End User
11.3.4. South Africa Nanopore Sequencing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Nucleotide Sequenced
11.3.4.2.3. By Type
11.3.4.2.4. By Type of Nanopore
11.3.4.2.5. By Application
11.3.4.2.6. By End User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Oxford Nanopore Technologies Ltd
14.2.2. Illumnia, Inc.
14.2.3. F Hoffmann-La Roche AG
14.2.4. 10X Genomics, Inc.
14.2.5. Agilent Technologies Inc.
14.2.6. NabSys, Inc.
14.2.7. Sequenom, Inc.
14.2.8. Quantapore, Inc
14.2.9. INanoBio Inc
14.2.10. Thermo Fischer Scientific, Inc.
14.2.11. Cyclomics BV
14.2.12. CD Genomics
14.2.13. Electronic Biosciences, Inc.
14.2.14. Easi-Genomics
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL NANOPORE SEQUENCING MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Product/Service Awareness
5.2. Brand Awareness
5.3. Factors affecting the choice of Nanopore
5.4. Commonly Used Nanopore Sequencing Methods
5.5. Factors Leading to adoption of Nanopore Sequencing
6. GLOBAL NANOPORE SEQUENCING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables v/s Instruments)
6.2.2. By Nucleotide Sequenced (DNA v/s RNA)
6.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)
6.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)
6.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)
6.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)
6.2.7. By Region
6.2.8. By Company (2020)
6.3. Product Market Map
7. NORTH AMERICA NANOPORE SEQUENCING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Nucleotide Sequenced
7.2.3. By Type
7.2.4. By Type of Nanopore
7.2.5. By Application
7.2.6. By End User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanopore Sequencing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Nucleotide Sequenced
7.3.1.2.3. By Type
7.3.1.2.4. By Type of Nanopore
7.3.1.2.5. By Application
7.3.1.2.6. By End User
7.3.2. Canada Nanopore Sequencing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Nucleotide Sequenced
7.3.2.2.3. By Type
7.3.2.2.4. By Type of Nanopore
7.3.2.2.5. By Application
7.3.2.2.6. By End User
7.3.3. Mexico Nanopore Sequencing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Nucleotide Sequenced
7.3.3.2.3. By Type
7.3.3.2.4. By Type of Nanopore
7.3.3.2.5. By Application
7.3.3.2.6. By End User
8. EUROPE NANOPORE SEQUENCING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Nucleotide Sequenced
8.2.3. By Type
8.2.4. By Type of Nanopore
8.2.5. By Application
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. United Kingdom Nanopore Sequencing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Nucleotide Sequenced
8.3.1.2.3. By Type
8.3.1.2.4. By Type of Nanopore
8.3.1.2.5. By Application
8.3.1.2.6. By End User
8.3.2. Germany Nanopore Sequencing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Nucleotide Sequenced
8.3.2.2.3. By Type
8.3.2.2.4. By Type of Nanopore
8.3.2.2.5. By Application
8.3.2.2.6. By End User
8.3.3. France Nanopore Sequencing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Nucleotide Sequenced
8.3.3.2.3. By Type
8.3.3.2.4. By Type of Nanopore
8.3.3.2.5. By Application
8.3.3.2.6. By End User
8.3.4. Russia Nanopore Sequencing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Nucleotide Sequenced
8.3.4.2.3. By Type
8.3.4.2.4. By Type of Nanopore
8.3.4.2.5. By Application
8.3.4.2.6. By End User
8.3.5. Turkey Nanopore Sequencing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Nucleotide Sequenced
8.3.5.2.3. By Type
8.3.5.2.4. By Type of Nanopore
8.3.5.2.5. By Application
8.3.5.2.6. By End User
8.3.6. Spain Nanopore Sequencing Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Product
8.3.6.2.2. By Nucleotide Sequenced
8.3.6.2.3. By Type
8.3.6.2.4. By Type of Nanopore
8.3.6.2.5. By Application
8.3.6.2.6. By End User
9. ASIA-PACIFIC NANOPORE SEQUENCING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Nucleotide Sequenced
9.2.3. By Type
9.2.4. By Type of Nanopore
9.2.5. By Application
9.2.6. By End User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Nanopore Sequencing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Nucleotide Sequenced
9.3.1.2.3. By Type
9.3.1.2.4. By Type of Nanopore
9.3.1.2.5. By Application
9.3.1.2.6. By End User
9.3.2. Japan Nanopore Sequencing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Nucleotide Sequenced
9.3.2.2.3. By Type
9.3.2.2.4. By Type of Nanopore
9.3.2.2.5. By Application
9.3.2.2.6. By End User
9.3.3. India Nanopore Sequencing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Nucleotide Sequenced
9.3.3.2.3. By Type
9.3.3.2.4. By Type of Nanopore
9.3.3.2.5. By Application
9.3.3.2.6. By End User
9.3.4. Singapore Nanopore Sequencing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Nucleotide Sequenced
9.3.4.2.3. By Type
9.3.4.2.4. By Type of Nanopore
9.3.4.2.5. By Application
9.3.4.2.6. By End User
9.3.5. Taiwan Nanopore Sequencing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Nucleotide Sequenced
9.3.5.2.3. By Type
9.3.5.2.4. By Type of Nanopore
9.3.5.2.5. By Application
9.3.5.2.6. By End User
9.3.6. Australia Nanopore Sequencing Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Product
9.3.6.2.2. By Nucleotide Sequenced
9.3.6.2.3. By Type
9.3.6.2.4. By Type of Nanopore
9.3.6.2.5. By Application
9.3.6.2.6. By End User
9.3.7. South Korea Nanopore Sequencing Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Product
9.3.7.2.2. By Nucleotide Sequenced
9.3.7.2.3. By Type
9.3.7.2.4. By Type of Nanopore
9.3.7.2.5. By Application
9.3.7.2.6. By End User
10. SOUTH AMERICA NANOPORE SEQUENCING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Nucleotide Sequenced
10.2.3. By Type
10.2.4. By Type of Nanopore
10.2.5. By Application
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanopore Sequencing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Nucleotide Sequenced
10.3.1.2.3. By Type
10.3.1.2.4. By Type of Nanopore
10.3.1.2.5. By Application
10.3.1.2.6. By End User
10.3.2. Argentina Nanopore Sequencing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Nucleotide Sequenced
10.3.2.2.3. By Type
10.3.2.2.4. By Type of Nanopore
10.3.2.2.5. By Application
10.3.2.2.6. By End User
10.3.3. Colombia Nanopore Sequencing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Nucleotide Sequenced
10.3.3.2.3. By Type
10.3.3.2.4. By Type of Nanopore
10.3.3.2.5. By Application
10.3.3.2.6. By End User
11. MIDDLE EAST AND AFRICA NANOPORE SEQUENCING MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Nucleotide Sequenced
11.2.3. By Type
11.2.4. By Type of Nanopore
11.2.5. By Application
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. UAE Nanopore Sequencing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Nucleotide Sequenced
11.3.1.2.3. By Type
11.3.1.2.4. By Type of Nanopore
11.3.1.2.5. By Application
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Nanopore Sequencing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Nucleotide Sequenced
11.3.2.2.3. By Type
11.3.2.2.4. By Type of Nanopore
11.3.2.2.5. By Application
11.3.2.2.6. By End User
11.3.3. Israel Nanopore Sequencing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Nucleotide Sequenced
11.3.3.2.3. By Type
11.3.3.2.4. By Type of Nanopore
11.3.3.2.5. By Application
11.3.3.2.6. By End User
11.3.4. South Africa Nanopore Sequencing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Nucleotide Sequenced
11.3.4.2.3. By Type
11.3.4.2.4. By Type of Nanopore
11.3.4.2.5. By Application
11.3.4.2.6. By End User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Oxford Nanopore Technologies Ltd
14.2.2. Illumnia, Inc.
14.2.3. F Hoffmann-La Roche AG
14.2.4. 10X Genomics, Inc.
14.2.5. Agilent Technologies Inc.
14.2.6. NabSys, Inc.
14.2.7. Sequenom, Inc.
14.2.8. Quantapore, Inc
14.2.9. INanoBio Inc
14.2.10. Thermo Fischer Scientific, Inc.
14.2.11. Cyclomics BV
14.2.12. CD Genomics
14.2.13. Electronic Biosciences, Inc.
14.2.14. Easi-Genomics
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF FIGURES
Figure 1: Global Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 3: Global Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 4: Global Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 5: Global Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 6: Global Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 8: Global Nanopore Sequencing Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Nanopore Sequencing Market Share, By Company, By Value, 2020
Figure 10: North America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 11: North America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 12: North America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 13: North America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 14: North America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 15: North America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 16: North America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 17: North America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 18: United States Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 19: United States Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 20: United States Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 21: United States Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 22: United States Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 23: United States Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 24: United States Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 25: Canada Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 26: Canada Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 27: Canada Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 28: Canada Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 29: Canada Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 30: Canada Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 31: Canada Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 32: Mexico Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 33: Mexico Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 34: Mexico Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 35: Mexico Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 36: Mexico Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 37: Mexico Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 38: Mexico Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 39: Europe Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 40: Europe Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 41: Europe Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 42: Europe Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 43: Europe Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 44: Europe Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 45: Europe Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 46: Europe Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 47: United Kingdom Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 48: United Kingdom Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 49: United Kingdom Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 50: United Kingdom Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 51: United Kingdom Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 52: United Kingdom Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 53: United Kingdom Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 54: Germany Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 55: Germany Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 56: Germany Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 57: Germany Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 58: Germany Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 59: Germany Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 60: Germany Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 61: France Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 62: France Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 63: France Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 64: France Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 65: France Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 66: France Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 67: France Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 68: Russia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 69: Russia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 70: Russia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 71: Russia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 72: Russia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 73: Russia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 74: Russia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 75: Turkey Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 76: Turkey Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 77: Turkey Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 78: Turkey Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 79: Turkey Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 80: Turkey Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 81: Turkey Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 82: Spain Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 83: Spain Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 84: Spain Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 85: Spain Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 86: Spain Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 87: Spain Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 88: Spain Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 89: Asia Pacific Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 90: Asia Pacific Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 91: Asia Pacific Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 92: Asia Pacific Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 93: Asia Pacific Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 94: Asia Pacific Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 95: Asia Pacific Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 96: Asia Pacific Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 97: China Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 98: China Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 99: China Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 100: China Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 101: China Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 102: China Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 103: China Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 104: Japan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 105: Japan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 106: Japan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 107: Japan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 108: Japan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 109: Japan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 110: Japan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 111: India Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 112: India Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 113: India Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 114: India Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 115: India Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 116: India Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 117: India Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 118: Singapore Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 119: Singapore Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 120: Singapore Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 121: Singapore Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 122: Singapore Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 123: Singapore Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 124: Singapore Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 125: Taiwan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 126: Taiwan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 127: Taiwan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 128: Taiwan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 129: Taiwan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 130: Taiwan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 131: Taiwan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 132: Australia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 133: Australia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 134: Australia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 135: Australia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 136: Australia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 137: Australia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 138: Australia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 139: South Korea Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 140: South Korea Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 141: South Korea Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 142: South Korea Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 143: South Korea Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 144: South Korea Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 145: South Korea Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 146: South America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 147: South America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 148: South America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 149: South America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 150: South America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 151: South America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 152: South America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 153: South America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figur
Figure 1: Global Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 3: Global Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 4: Global Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 5: Global Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 6: Global Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 7: Global Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 8: Global Nanopore Sequencing Market Share, By Region, By Value, 2016-2026F
Figure 9: Global Nanopore Sequencing Market Share, By Company, By Value, 2020
Figure 10: North America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 11: North America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 12: North America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 13: North America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 14: North America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 15: North America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 16: North America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 17: North America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 18: United States Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 19: United States Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 20: United States Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 21: United States Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 22: United States Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 23: United States Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 24: United States Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 25: Canada Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 26: Canada Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 27: Canada Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 28: Canada Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 29: Canada Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 30: Canada Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 31: Canada Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 32: Mexico Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 33: Mexico Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 34: Mexico Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 35: Mexico Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 36: Mexico Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 37: Mexico Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 38: Mexico Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 39: Europe Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 40: Europe Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 41: Europe Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 42: Europe Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 43: Europe Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 44: Europe Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 45: Europe Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 46: Europe Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 47: United Kingdom Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 48: United Kingdom Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 49: United Kingdom Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 50: United Kingdom Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 51: United Kingdom Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 52: United Kingdom Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 53: United Kingdom Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 54: Germany Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 55: Germany Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 56: Germany Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 57: Germany Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 58: Germany Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 59: Germany Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 60: Germany Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 61: France Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 62: France Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 63: France Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 64: France Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 65: France Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 66: France Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 67: France Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 68: Russia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 69: Russia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 70: Russia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 71: Russia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 72: Russia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 73: Russia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 74: Russia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 75: Turkey Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 76: Turkey Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 77: Turkey Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 78: Turkey Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 79: Turkey Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 80: Turkey Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 81: Turkey Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 82: Spain Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 83: Spain Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 84: Spain Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 85: Spain Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 86: Spain Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 87: Spain Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 88: Spain Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 89: Asia Pacific Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 90: Asia Pacific Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 91: Asia Pacific Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 92: Asia Pacific Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 93: Asia Pacific Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 94: Asia Pacific Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 95: Asia Pacific Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 96: Asia Pacific Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figure 97: China Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 98: China Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 99: China Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 100: China Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 101: China Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 102: China Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 103: China Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 104: Japan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 105: Japan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 106: Japan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 107: Japan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 108: Japan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 109: Japan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 110: Japan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 111: India Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 112: India Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 113: India Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 114: India Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 115: India Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 116: India Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 117: India Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 118: Singapore Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 119: Singapore Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 120: Singapore Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 121: Singapore Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 122: Singapore Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 123: Singapore Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 124: Singapore Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 125: Taiwan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 126: Taiwan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 127: Taiwan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 128: Taiwan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 129: Taiwan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 130: Taiwan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 131: Taiwan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 132: Australia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 133: Australia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 134: Australia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 135: Australia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 136: Australia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 137: Australia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 138: Australia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 139: South Korea Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 140: South Korea Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 141: South Korea Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 142: South Korea Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 143: South Korea Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 144: South Korea Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 145: South Korea Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 146: South America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
Figure 147: South America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
Figure 148: South America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
Figure 149: South America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
Figure 150: South America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
Figure 151: South America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
Figure 152: South America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
Figure 153: South America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
Figur
